More is not always better: 2 weeks of intensive cognitive processing therapy-based treatment are noninferior to 3 weeks.


Journal

Psychological trauma : theory, research, practice and policy
ISSN: 1942-969X
Titre abrégé: Psychol Trauma
Pays: United States
ID NLM: 101495376

Informations de publication

Date de publication:
Jan 2023
Historique:
pmc-release: 01 01 2024
entrez: 19 1 2023
pubmed: 20 1 2023
medline: 24 1 2023
Statut: ppublish

Résumé

Although there is mounting evidence that massed treatment for PTSD is both feasible and effective, many questions remain about the optimal length of intensive treatment programs (ITPs), as well as the role of adjunctive services, such as psychoeducation, mindfulness, and yoga. Our setting recently transitioned from a three-week ITP to a two-week program. Adjunctive services were reduced, but the amount of individual CPT between programs remained similar. The present study examined the effectiveness of a two-week ITP based on twice daily individual CPT sessions and evaluated the program's noninferiority to an established three-week ITP using a Bayesian analytical approach. Bayesian linear mixed regression models were used to explore PTSD and depression changes over time, as well as predictors of change. Noninferiority of the two-week ITP to a three-week ITP was also established using a Bayes factor approach. Results indicate that program participants change meaningfully in both PTSD and depression severity over the course of treatment, and that changes in posttraumatic cognitions predict subsequent changes in these outcomes. Further, the two-week ITP can be considered noninferior to the three-week ITP in both clinical outcomes and overall satisfaction. In the context of intensive PTSD treatment, the content of the ITP appears to matter more than its overall length. Shorter programs have the potential to increase access and treatment capacity. Our findings demonstrate the importance of continuous and rigorous program evaluation. Limitations as well as future directions for research, such as identifying the most effective treatment components, are discussed. (PsycInfo Database Record (c) 2023 APA, all rights reserved).

Identifiants

pubmed: 36656744
pii: 2022-58575-001
doi: 10.1037/tra0001257
pmc: PMC10258911
mid: NIHMS1896103
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100-109

Subventions

Organisme : AHRQ HHS
ID : R21 HS028511
Pays : United States

Références

J Affect Disord. 2020 May 15;269:134-140
pubmed: 32250866
J Consult Clin Psychol. 2008 Apr;76(2):243-258
pubmed: 18377121
Behav Ther. 2018 Sep;49(5):741-755
pubmed: 30146141
Am J Psychiatry. 2014 Mar;171(3):294-304
pubmed: 24480899
Cogn Behav Ther. 2019 Jan;48(1):1-14
pubmed: 30332919
Cognit Ther Res. 2020 Feb 27;44(3):611-620
pubmed: 35431370
Curr Psychiatry Rep. 2015 Apr;17(4):560
pubmed: 25749748
J Clin Psychol. 2018 Dec;74(12):2070-2081
pubmed: 29917224
Cogn Behav Pract. 2020 May;27(2):126-135
pubmed: 33041618
JAMA. 2018 Jan 23;319(4):354-364
pubmed: 29362795
Psychol Assess. 2018 Mar;30(3):383-395
pubmed: 28493729
Eur J Psychotraumatol. 2020 Aug 12;11(1):1789324
pubmed: 33029327
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Psychol Assess. 2016 Nov;28(11):1379-1391
pubmed: 26653052
J Consult Clin Psychol. 2006 Oct;74(5):898-907
pubmed: 17032094
Eur J Psychotraumatol. 2020 Jul 23;11(1):1783955
pubmed: 33029323
BMC Psychiatry. 2018 Jul 27;18(1):242
pubmed: 30053860
Cogn Behav Pract. 2021 Nov;28(4):543-554
pubmed: 34629839
BMC Med Res Methodol. 2019 Mar 29;19(1):71
pubmed: 30925900
J Anxiety Disord. 2017 Aug;50:23-32
pubmed: 28545005
Behav Res Ther. 2009 Sep;47(9):737-43
pubmed: 19595295
Behav Res Ther. 2002 Apr;40(4):439-57
pubmed: 12002900
J Trauma Stress. 2020 Aug;33(4):443-454
pubmed: 32598561
Eur J Psychotraumatol. 2021 Jun 14;12(1):1888541
pubmed: 34178292
Focus (Am Psychiatr Publ). 2017 Oct;15(4):378-383
pubmed: 31975867
JAMA Psychiatry. 2017 Jan 01;74(1):28-36
pubmed: 27893032
Behav Ther. 2017 Mar;48(2):195-206
pubmed: 28270330
J Consult Clin Psychol. 2015 Dec;83(6):1058-1068
pubmed: 25939018
Eur J Psychotraumatol. 2021 Jan 15;12(1):1851511
pubmed: 34630934
J Interpers Violence. 2021 Dec;36(23-24):10989-11008
pubmed: 31898925

Auteurs

Philip Held (P)

Department of Psychiatry and Behavioral Sciences.

Dale L Smith (DL)

Department of Psychiatry and Behavioral Sciences.

Sarah Pridgen (S)

Department of Psychiatry and Behavioral Sciences.

Jennifer A Coleman (JA)

Department of Psychiatry and Behavioral Sciences.

Brian J Klassen (BJ)

Department of Psychiatry and Behavioral Sciences.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH